ISRCTN84288072已完成未知
A randomised controlled trial evaluating the feasibility and acceptability of a time limited anxiety intervention in bipolar disorder
ancaster University (UK)0 个研究点目标入组 72 人开始时间: 2011年3月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 72
研究概览
简要总结
- 2013 results in http://www.ncbi.nlm.nih.gov/pubmed/23414176
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Primary diagnosis of bipolar I or II disorder
- •2. Current experience of anxiety evidenced by a HADS-A score > 8
- •3. Aged 18+
- •4. Ability to understand spoken and written English to a level where participants are able to provide written informed consent and are able to participate in interviews, questionnaires and therapy sessions, where appropriate.
- •5. Male or Female
排除标准
- •1. Current experience of a manic, hypomanic, depressed or mixed episode, or experience of this in the past four weeks, although it is expected that some subsyndromal symptoms will be present
- •2. Current suicidal ideation with intent
研究者
相似试验
已完成
不适用
iQuit in practice: a study to examine a personalised web-and text message programme to support smoking cessation in Primary CareMental and Behavioural DisordersSmoking cessationMental and behavioural disorders due to use of tobaccoISRCTN56702353niversity of Cambridge (UK)600
已完成
不适用
Diabetes Intervention for Agenda Trial: study of the efficacy of a patient-orientated agenda (produced by the PACE-D tool) for use in a diabetes clinical consultatioDiabetes mellitusTopic: Diabetes Research NetworkSubtopic: BothDisease: Diabetic ControlNutritional, Metabolic, EndocrineISRCTN75070242Royal Devon and Exeter NHS Foundation Trust (UK)120
已完成
3 期
nited Kingdom childhood Acute Lymphoblastic Leukaemia Randomised Trial 2003eukaemiaLymphoid leukaemiaCancerISRCTN07355119niversity of Sheffield (UK)2,500
已完成
不适用
Brief intervention for weight lossObesity in primary careNutritional, Metabolic, EndocrineObesityISRCTN26563137niversity of Oxford (UK)1,882
已完成
不适用
FOCUS 3 - the feasibility of molecular selection of therapy using KRAS, BRAF and topo-1 in patients with metastatic or locally advanced colorectal cancerCancerISRCTN83171665Medical Research Council (UK)240